Bluebook
Diagnostics and Tools BlueBook January 2025
2025 - January: Report on M&A and financing activity in the diagnostics and tools industry for CEOs and private equity professionals
Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.
Highlights from this edition:
- Akoya Biosciences was acquired by Quanterix
- Freeman Capital announced its acquisition of Diesse
- Northlane Capital Partners announced its acquisition of United States Drug Testing Laboratories
- SpinChip Diagnostics was acquired by bioMerieux